Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients

Degano B. , Mittaine M. , Herve P. , Rami J. , Kamar N. , Suc B. , Riviere D. , Rostaing L.

Source: Eur Respir J 2009; 34: 138-144
Journal Issue: July
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Degano B. , Mittaine M. , Herve P. , Rami J. , Kamar N. , Suc B. , Riviere D. , Rostaing L.. Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients. Eur Respir J 2009; 34: 138-144

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide
Source: Eur Respir J 2007; 30: 26-30
Year: 2007



Exhaled nitric oxide after lung transplantation: impact of the native lung
Source: Eur Respir J 2003; 21: 429-432
Year: 2003



Exhaled nitric oxide is not reduced in infants with cystic fibrosis
Source: Eur Respir J 2006; 27: 350-354
Year: 2006



An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis
Source: Eur Respir J 2004; 24 : 609-614
Year: 2004



Exhaled nitric oxide in stable adult cystic fibrosis patients, during exacerbation and following CFTR-modifying treatment
Source: Eur Respir J, 53 (5) 1802259; 10.1183/13993003.02259-2018
Year: 2019



Reduced exhaled nitric oxide in infants with cystic fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 384s
Year: 2004

Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases
Source: International Congress 2015 – IIPs: orphan
Year: 2015


Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients
Source: Eur Respir J 2001; 17: 1267-1270
Year: 2001



Fractional exhaled nitric oxide levels in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity
Year: 2016


Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011


Exhaled nitric oxide levels in patients with pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016


Exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017

Elevated levels of alveolar nitric oxide in patients with inflammatory bowel disease
Source: International Congress 2016 – Airway biomarkers
Year: 2016


Inhaled nitric oxide decreases pulmonary endothelial nitric oxide synthase expression and activity in normal newborn rat lungs
Source: ERJ Open Res 2016
Year: 2016


Nitric oxide (NO) in exhaled breath helps to distinguish the origin of lung infiltrate
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012

Extended measurement of exhaled nitric oxide in patients after lung transplantation
Source: Eur Respir J 2005; 26: Suppl. 49, 705s
Year: 2005

Measurement of alveolar nitric oxide in patients with lung cancer
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012

Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments
Source: Eur Respir J 2009; 34: 117-124
Year: 2009



Role of the nitric oxide in the lung function and airway hyperreactivity in silicotic mice
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013